Perspective · 10 Sep 2026
Conference abstractPublished 15 Oct 2013
Universal biopanning strategy to identify epitopes associated with antibody-mediated vaccine protection against infectious pathogens
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Identifying the immune correlates of protection is a key aspect of developing vaccines against infectious pathogens. We designed a universally applicable strategy to profile the antibody (Ab) repertoire of protected vaccine recipients, using recombinant phages encoding random peptide libraries. The novel approach, termed ?protection-linked (PL) biopanning,? uses subtractive biopanning and probes Ab paratopes of protected vaccinees (?winners?) versus those with vaccine failure (?losers?). As proof-of- concept, we screened plasma samples from vaccinated macaques that had completely resisted multiple mucosal challenges with CCR5-tropic simian-human immunodeficiency viruses (SHIVs). The animals had been immunized with multimeric HIV-1 gp160 (Env), HIV-1 Tat, and SIV Gag-Pol particles. PL biopanning yielded a panel of approximately 100 recombinant phages that specifically reacted with Abs from ?winners? and partially protected macaques but not Abs from ?losers? or non-vaccinated, virus-challenged controls. Only about half of the phagotopes selected revealed amino acid homologies with HIV-1 Env (Env mimotopes). Expanding the sequence analysis to include non-Env immunogens revealed an unexpected additional humoral correlate of protection: the neutralizing epitope of HIV-1 Tat. Functional assays confirmed the induction of neutralizing anti-Tat Abs in macaques with full or partial protection but not in those with vaccine failure. Our data suggest that Tat should be included in multicomponent HIV-1 vaccines-and highlight the power of the new PL-biopanning strategy to identify Ab responses with significant association to vaccine protection, regardless of the mechanism(s) or targets of the protective Abs. PL biopanning is unbiased with regard to pathogens or disease model, making it a universal tool.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Ruth M. Ruprecht”
